Amazon Web Services, Inc. (AWS) announced the selection of Gilead Sciences, Inc. as its preferred cloud provider, a biopharmaceutical company that develops innovative medicines to prevent and treat life-threatening diseases. Gilead’s data scientists benefit from the latest advancements in machine learning (ML) and analytics using AWS and AWS experts and partners in life sciences and healthcare.
Marc Berson, Senior Vice President, and Chief Information Officer at Gilead said, “With AWS as our preferred cloud provider, our researchers can use AWS’s portfolio of services to gain the insights, agility, and security needed to deliver new medicines at speed, and treat the individual according to their unique needs, not just the disease. AWS’s performance, infrastructure, and scale are the foundations on which we will complete our ERP transformation and become a more efficient, agile, secure, and data-driven business in the cloud.”
Gilead uses these capabilities across its entire organization, from biomarker discovery to manufacturing and clinical trial recruitment, to drive data-driven decision-making and refine its drug pipeline. In addition, the company relies on AWS to host all of its enterprise resource planning (ERP) workloads for its SAP S/4HANA implementation project.
Matt Garman, Senior Vice President of Sales and Marketing at Amazon Web Services, Inc, said, “Gilead uses the proven performance of the world’s leading cloud to innovate, scale, and deliver powerful therapies for diseases like HIV and cancer, as well as advance standards for precision medicine. By streamlining its IT operations with AWS and taking advantage of our AWS for Health offerings, Gilead has the ability to continuously refine its approach to clinical trials, drug development, manufacturing, and distribution. AWS provides the security and privacy that healthcare and life sciences companies need, as well as the expertise and breadth and depth of services they can rely on to build transformative healthcare solutions that enhance health and wellbeing.”
Cloud computing is transforming Gilead’s bioinformatics compute infrastructure. By leveraging AWS’s compute, machine learning, and database capabilities, Gilead will be able to integrate diverse genomics, imaging, and experimental datasets to find new ways of diagnosing and treating illnesses. Gilead, for example, is able to uncover insights on how patients living with cancer respond to existing treatments by securely analyzing de-identified genomic data at scale on AWS to reveal patterns, potentially accelerating the discovery of new treatments.
Also in Gilead’s IT organization, AWS is used to host all workloads on behalf of its ERP transformation project to implement SAP S/4HANA. These systems facilitate performance-critical activities in areas such as finance, operations, and commercial sales across all therapeutic areas and business units. AWS provides Gilead with a foundation for implementing SAP S/4HANA, as well as a means of shortening hardware refresh cycles, improving testing agility, and enhancing business planning.
